St. Agnes Hospital St. Agnes Hospital (2) is a clinical research site located in Baltimore, Maryland, United States 21229.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
St. Agnes Hospital St. Agnes Hospital (2) has participated in 3 clinical trials.
Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, Tumors With CDK4/6 Pathway Activation, Solid Tumor.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
St. Agnes Hospital St. Agnes Hospital (2) has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St. Agnes Hospital St. Agnes Hospital (2) has 3 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, Tumors With CDK4/6 Pathway Activation, Solid Tumor.
St. Agnes Hospital St. Agnes Hospital (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.